1/19/2026NMPA Announces Adoption of ICH Q8/Q9/Q10 Q&A (R5) Guidelines for Drug ...

1/19/2026Biyo Secures ~CNY 100M in Pre-A Funding as Lead Migraine Biologic Adva...

1/19/2026ABM Thera Licenses MEK1/2 Inhibitor ABM-168 to Mosaica Medicines for G...

1/19/2026Henlius Biotech Secures Global Rights to IL-1RAP Antibody from U-mab B...

1/19/2026AstraZeneca Acquires Full Global Rights to AbelZeta’s GPC3 Armored CA...

1/17/2026Recent Executive Moves

1/16/2026Takeda Submits China Marketing Application for Obretone Tablets

1/16/2026AmCham China Survey Shows Resilience and Improving Performance Among U...

1/16/2026HEC Pharma Wins China Approval for Olorigliflozin in Type 2 Diabetes

1/16/2026China's NMPA to Mandate eCTD Submission Starting March 1

1/16/2026WuXi Biologics and WuXi XDC Launch HK$1.86B Takeover Bid for BioDLink

1/16/2026Exegenesis Files for HKSE IPO to Advance Gene and Oligonucleotide Ther...

1/16/2026Zenitar Files for HKSE IPO Following $87M Series C Raise

1/16/2026Sanofi Gains Approval for Two Innovative Therapies in China

1/16/2026Simcere Zaiming Files for Hong Kong IPO to Accelerate Oncology Pipelin...

1/14/2026Chinese Scientists Unveil Novel Intratumoral Vaccine

1/14/2026Caldera Launches with $112.5 Million to Advance China-Licensed IBD Bs...

1/14/2026Pfizer Announces Completion of Key China Phase 3 Trial for Migraine Dr...

1/14/2026NHSA Seeks Feedback on Draft Guidelines for Real-World Drug Value Ass...

1/14/2026Sino Biopharma Completes Full Acquisition of Hygieia for CNY 1.2B

1/14/2026Signet Thera Raises CNY 80M in Series A

1/14/2026XellSmart Completes Series C1 Financing

1/14/2026GenHouse Bio Secures CNY 300M+ in Crossover Financing

1/13/2026Vibrant Thera Raises $61M to Advance Logic-Gated Cancer Immunotherapie...

1/13/2026Abbisko's Pimicotinib Advances Toward U.S. Approval as FDA Accepts NDA

1/13/2026Novartis Expands Radioligand Therapy Pipeline with Licensing Deal from...

1/13/2026China Weighs Approval of Russian Cancer Vaccine

1/12/2026Anticancer Bioscience Secures Angel Funding to Advance Precision Oncol...

1/12/2026Eli Lilly Submits Orforglipron NDA in China for GLP-1R Agonist

1/12/2026AbbVie Secures Global Rights to RemeGen’s PD-1/VEGF Bispecific RC148 ...

Page:1/59 Total number of articles:1744: [First][<<] [1] [2] [3] [4] [5] [>>] [End]